900000000000509007: Amerikaans-Engelse taalreferentieset (metadata)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx)	Preferred (foundation metadata concept)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades choroid focally (retinoblastoma)	Preferred (foundation metadata concept)
pT2b: Tumor invades choroid focally (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder)	Preferred (foundation metadata concept)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades subserosa (stomach)	Preferred (foundation metadata concept)
pT2b: Tumor invades subserosa (stomach) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) (finding)	Preferred (foundation metadata concept)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate)	Preferred (foundation metadata concept)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) (finding)	Preferred (foundation metadata concept)
pT2c	Preferred (foundation metadata concept)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT2c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2c category	Preferred (foundation metadata concept)
pT2c category (finding)	Preferred (foundation metadata concept)
pT2c: Bilateral disease (prostate)	Preferred (foundation metadata concept)
pT2c: Bilateral disease (prostate) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma)	Preferred (foundation metadata concept)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2d	Preferred (foundation metadata concept)
pT2d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT3	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri)	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva)	Preferred (foundation metadata concept)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) (finding)	Preferred (foundation metadata concept)
pT3 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT3 category	Preferred (foundation metadata concept)
pT3 category (finding)	Preferred (foundation metadata concept)
pT3 stage	Acceptable (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (bone)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (bone) (finding)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate) (finding)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts)	Preferred (foundation metadata concept)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma)	Preferred (foundation metadata concept)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor >5 cm in greatest dimension (breast)	Acceptable (foundation metadata concept)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma)	Preferred (foundation metadata concept)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas)	Preferred (foundation metadata concept)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota fascia (kidney)	Acceptable (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney)	Preferred (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus)	Preferred (foundation metadata concept)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands)	Preferred (foundation metadata concept)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades adventitia (esophagus)	Preferred (foundation metadata concept)
pT3: Tumor invades adventitia (esophagus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus)	Preferred (foundation metadata concept)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades pancreas (ampulla of Vater)	Preferred (foundation metadata concept)
pT3: Tumor invades pancreas (ampulla of Vater) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades perivesical tissue (urinary bladder)	Preferred (foundation metadata concept)
pT3: Tumor invades perivesical tissue (urinary bladder) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts)	Preferred (foundation metadata concept)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis)	Preferred (foundation metadata concept)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix)	Preferred (foundation metadata concept)

Start Previous Page 13364 of 13382 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
8203031000146117	Amerikaans-Engelse taalreferentieset (metadata)	nl	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
8203041000146113	taalreferentieset voor Amerikaans-Engels	nl	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
8203051000146111	Amerikaans-Engelse taalreferentieset	nl	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)